Bevacizumab Concentrate for Infusion | Bevatas - INTAS

Advanced Targeted Oncology Care

When addressing specific and complex oncology needs, healthcare providers require infusion treatments that deliver highly precise, targeted, and reliable results. The Bevacizumab Concentrate for Solution for Infusion (commercially recognized as Bevatas) provides a potent clinical therapy designed to support critical long-term treatment plans. Manufactured by INTAS Pharmaceuticals, a globally respected leader in medical research and manufacturing, this sterile concentrate ensures the steady clinical performance necessary for patients navigating advanced health challenges.

Why Choose Bevatas for Clinical Management?

Managing intensive oncology conditions requires strict clinical protocols and highly reliable medication delivery. Instead of utilizing unpredictable formulations, hospitals and clinical infusion centers benefit from Bevatas’s meticulously engineered single-use vials, which guarantee exact dosing and uncompromised sterility. INTAS provides the built-in trust, stringent quality control, and proven efficacy that oncologists, specialized clinics, and leading pharmacies demand when stocking life-saving specialty infusions.

Key Product Specifications & Clinical Benefits

Targeted Active Ingredient: Contains premium-grade Bevacizumab, a specialized formulation clinically designed for advanced oncology care regimens.

Precise Dosing Options: Available in two specific strengths—100 mg / 4 mL and 400 mg / 16 mL—equipping clinical staff to accurately calculate and prepare customized patient infusions.

Standardized Strength: Both vial sizes maintain a consistent base strength of 25 mg/mL, simplifying clinical preparation and dilution protocols.

Contamination Prevention: Packaged strictly as single-use vials to maintain absolute sterility and safeguard against cross-contamination in sensitive oncology wards.

Essential Storage & Preparation Guidelines

Protecting the integrity of this specialized medication is vital for its clinical efficacy. Store the vials strictly in a refrigerator between 2°C to 8°C. Do not freeze. Keep the vial in its outer carton to protect it from light until the exact moment of clinical preparation.

Important Notice: Bevatas is a highly specialized prescription medication. Warning: To be sold by retail on the prescription of an Oncologist only. It must be prescribed, diluted for IV infusion, and administered strictly by a Registered Medical Practitioner in a clinical setting.